Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression Interim clinical trial data presented at American Vein and ...
OAKLAND, Calif., September 04, 2024--(BUSINESS WIRE)--Koya Medical, a healthcare company with a mission to transform venous and lymphatic treatments through novel, people-centric solutions, today ...
Koya Medical has shared data highlighting that its non-pneumatic compression device (NPCD) demonstrated better efficacy and improved quality of life in patients with lower extremity lymphedema. The ...
OAKLAND, Calif.--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received ...
OAKLAND, Calif., October 04, 2022--(BUSINESS WIRE)--Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric ...
OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial. TEAYS (NCT05507346) is a prospective multi-center, randomized ...
OAKLAND, Calif., Jan. 14, 2021 /PRNewswire/ -- Koya Medical (www.koyamedical.com), a healthcare company focused on treating lymphedema and vein disease, today announced the close of a $11 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results